Induction of apoptosis underlies the Radix Rubiae-mediated anti-proliferative action on human epidermal keratinocytes: Implications for psoriasis treatment

International Journal of Molecular Medicine

Volumn 20, Issue 5, 2007, Pages 663-672

  Tse, Wai Pui ^a   Cheng, Christopher H K ^b   Che, Chun Tao ^a   Zhao, Ming ^a   Lin, Zhi Xiu ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

Anti proliferative action; Apoptosis; HaCaT keratinocytes; Psoriasis; Radix Rubiae

Indexed keywords

CASPASE 3; HERBACEOUS AGENT; LIPOCORTIN 5; PLANT EXTRACT; PROPIDIUM IODIDE; PYRAN DERIVATIVE; RUBIMAILLIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CELL SHAPE; CYTOLOGY; DNA FRAGMENTATION; DRUG EFFECT; ENZYMOLOGY; EPIDERMIS; FLOW CYTOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KERATINOCYTE; METABOLISM; NECROSIS; NICK END LABELING; PATHOLOGY; PHYTOTHERAPY; PSORIASIS; WESTERN BLOTTING;

ANNEXIN A5; APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CELL CYCLE; CELL PROLIFERATION; CELL SHAPE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA FRAGMENTATION; DRUGS, CHINESE HERBAL; EPIDERMIS; FLOW CYTOMETRY; HUMANS; IN SITU NICK-END LABELING; KERATINOCYTES; NECROSIS; PHYTOTHERAPY; PLANT EXTRACTS; PROPIDIUM; PSORIASIS; PYRANS;

EID: 38449102690     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Lebwohl M: Psoriasis. Lancet 361: 1197-1204, 2003.
2. Nickoloff BJ and Nestle FO: Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J Clin Invest 113: 1664-1675, 2004.
3. Camisa C: Handbook of Psoriasis. Blackwell Science, Malden, p137, 1998.
4. Schwartz PM, Barnett SK, Atillasoy ES and Milstone LM: Methotrexate induces differentiation of human keratinocytes. Proc Natl Acad Sci USA 89: 594-598, 1992.
5. Pol A, Bergers M and Schalkwijk J: Comparison of antiproliferative effects of experimental and established antipsoriatic drugs on human keratinocytes, using a simple 96-well-plate assay. In Vitro Cell Dev Biol Anim 39: 36-42, 2003.
6. Takahashi H, Ibe M, Kinouchi M, Ishida-Yamamoto A, Hashimoto Y and Iizuka H: Similarly potent action of 1,25-dihydroxyvitamin D3 and its analogues, tacalcitol, calcipotriol, and maxacalcitol on normal human keratinocyte proliferation and differentiation. J Dermatol Sci 31: 21-28, 2003. (Pubitemid 36286955)
7. Bayliffe AI, Brigandi RA, Wilkins HJ and Levick MP: Emerging therapeutic targets in psoriasis. Curr Opin Pharmacol 4: 306-310, 2004.
8. Takahashi H and Iizuka H: Treatment of the keratinizing skin disorder, psoriasis, by topical vitamin D3. Clin Calcium 10: 129-132, 2004.
9. Wrone-Smith T, Mitra RS, Thompson CB, Jasty R, Castle VP and Nickoloff BJ: Keratinocytes derived from psoriatic plaques are resistant to apoptosis compared with normal skin. Am J Pathol 151: 1321-1329, 1997.
10. Laporte M, Galand P, Fokand D, de Graef C and Heenen M: Apoptosis in established and healing psoriasis. Dermatology 200: 314-316, 2000.
11. Bianchi L, Farrace MG, Nini G and Piacentini M: Abnormal Bcl-2 and 'tissue' transglutaminase expression in psoriatic skin. J Invest Dermatol 103: 829-833, 1994.
12. Reed JC: Bcl-2 family proteins. Oncogene 17: 3225-3236, 1998.
13. Kawashima K, Doi H, Ito Y, Shibata MA, Yoshinaka R and Otsuki Y: Evaluation of cell death and proliferation in psoriatic epidermis. J Dermatol Sci 35: 207-214, 2004.
14. Tse WP, Che CT, Liu K and Lin ZX: Evaluation of the antiproliferative properties of selected psoriasis-treating Chinese medicines on cultured HaCaT cells. J Ethnopharmacol 108: 133-141, 2006.
15. Chen R and Wang ZS: The isolation and elucidation of mollugin from Radix Rubiae. Cir Chin Materia Medica 13: 39, 1988.
16. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A and Fusenig NE: Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106: 761-771, 1988.
17. Garach-Jehoshua O, Ravid A, Liberman UA and Koren R: 1,25- Dihydroxyvitamin D3 increases the growth-promoting activity of autocrine epidermal growth factor receptor ligands in keratinocytes. Endocrinology 140: 713-721, 1999. (Pubitemid 29058205)
18. Farkas A, Kemeny L, Szony BJ, Bata-Csorgo Z, Pivarcsi A, Kiss M, Szell M, Koreck A and Dobozy A: Dithranol upregulates IL-10 receptors on the cultured human keratinocyte cell line HaCaT. Inflamm Res 50: 44-49, 2001. (Pubitemid 32156118)
19. Thielitz A, Bukowska A, Wolke C, Vetter R, Lendeckel U, Wrenger S, Hashimoto Y, Ansorge S, Gollnick H and Reinhold D: Identification of extra- and intracellular alanyl aminopeptidases as new targets to modulate keratinocyte growth and differentiation. Biochem Biophys Res Commun 321: 795-801, 2004. (Pubitemid 39044380)
20. Nicoletti I, Migliorati G, Pagliacci MC, Grignani E and Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139: 271-279, 1991.
21. Tounekti O, Belehradek J Jr and Mir LM: Relationships between DNA fragmentation, chromatin condensation, and changes in flow cytometry profiles detected during apoptosis. Exp Cell Res 217: 506-516, 1995.
22. Abrams JM, White K, Fessler LI and Steller H: Programmed cell death during Drosophila embryogenesis. Development 117: 29-43, 1993.
23. Gavrieli Y, Sherman Y and Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493-501, 1992.
24. Portera-Cailliau C, Sung CH, Nathans J and Adler R: Apoptotic photoreceptor cell death in mouse models of retinitis pigmentosa. Proc Natl Acad Sci USA 91: 974-978, 1994.
25. Sgonc R, Boeck G, Dietrich H, Gruber J, Recheis H and Wick G: Simultaneous determination of cell surface antigens and apoptosis. Trends Genet 10: 41-42, 1994.
26. Ernst JD, Yang L, Rosales JL and Broaddust VC: Preparation and characterization of an endogenously fluorescent annexin for detection of apoptotic cells. Anal Biochem 260: 18-23, 1998.
27. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL and Henson PM: Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 148: 2207-2216, 1992.
28. Martin SJ, Reutelingsperger CP, McGahon AJ, Rader JA, van Schie RC, LaFace DM and Green DR: Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 182: 1545-1556, 1995.
29. Vermes I, Haanen C, Steffens-Nakken H and Reutelingsperger C: A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 184: 39-51, 1995.
30. Boehm I: Apoptosis in physiological and pathological skin: Implications for therapy. Curr Mol Med 6: 375-394, 2006.
31. Krueger JG, Wolfe JT, Nabeya RT, Vallat VP, Gilleaudeau P, Heftler NS, Austin LM and Gottlieb AB: Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells. J Exp Med 182: 2057-2068, 1995.
32. Benassi L, Ottani D, Fantini F, Marconi A, Chiodino C, Giannetti A and Pincelli C: 1,25-dihydroxyvitamin D3, transforming growth factor beta1, calcium, and ultraviolet B radiation induce apoptosis in cultured human keratinocytes. J Invest Dermatol 109: 276-282, 1997.
33. McGill A, Frank A, Emmett N, Turnbull D, Birch-Machin MA and Reynolds NJ: The anti-psoriatic drug anthralin accumulates in keratinocyte mitochondria, dissipates mitochondrial membrane potential, and induces apoptosis through a pathway dependent on respiratory competent mitochondria. FASEB J 19: 1012-1014, 2005. (Pubitemid 40827735)
34. Lei ZQ, Chen SY and Gao XM (eds): Chinese Materia Medica. Shanghai Science and Technology Press, Shanghai, p189, 1995.
35. Fang XY, Sun YH, Yang LS and Miao MS: Progress in the research on Rubiae Cordifolia. Arch Henan Chin Med 17: 78-80, 2002.
36. Compton MM: A biochemical hallmark of apoptosis: internucleosomal degradation of the genome. Cancer Metastasis Rev 11: 105-119, 1992.
37. Wyllie AH: Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284: 555-556, 1980.
38. Barry MA and Eastman A: Identification of deoxyribonuclease II as an endonuclease involved in apoptosis. Arch Biochem Biophys 300: 440-450, 1993.
39. Hoshi T, Sasano H, Kato K, Yabuki N, Ohara S, Konno R, Asaki S, Toyota T, Tateno H and Nagura H: Immunohistochemistry of Caspase3/CPP32 in human stomach and its correlation with cell proliferation and apoptosis. Anticancer Res 18: 4347-4353, 1998.
40. Kirsch DG, Doseff A, Chau BN, Lim DS, De Souza-Pinto NC, Hansford R, Kastan MB, Lazebnik YA and Hardwick JM: Caspase-3-dependent cleavage of Bcl-2 promotes release of cytochrome. J Biol Chem 274: 21155-21161, 1999.